))
Episode 08 - Identification of ACE2 modifiers by CRISPR screening
Manage episode 300191562 series 2942968
Content provided by Dr Jonny Coates. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Jonny Coates or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This week we discuss high throughput CRISPR/Cas9 screening and how these have been adapted to investigate novel treatments for COVID-19 with Emily Sherman a former Post Doc and Brian Emmer (@brianemmer), a new PI at University of Michigan (@UMIntMed)
In this episode we cover details on how to conduct a high throughput CRISPR/Cas9 screen, the exciting advances in NextGen sequencing as well as what it's like to set up your own lab while working as a clinician during a pandemic. We also speak to Emily about her transition from academia to industry and our usual discussion about the benefits of preprints.
Read the full preprint - https://www.biorxiv.org/content/10.1101/2021.06.10.447768v1.full
Brian’s lab homepage (https://emmer.lab.medicine.umich.edu/)
https://www.nature.com/articles/nm1267
This episode was produced by Emma Wilson and edited by Jonny Coates and John D Howard.
If you enjoyed this show then hit that subscribe button and leave a review. If you love what we are trying to do then support us on Patreon https://www.patreon.com/preprintsinmotion where tiers start at as little as £1 a month!
For the latest podcast news and updates follow us on Twitter @MotionPod or visit our website; www.preprintsinmotion.com.
Produced by JEmJ Productions (find us on Twitter: Jonny @JACoates, Emma @ELWilson92, John @JohnDHoward8) and generously supported by ASAPbio (https://asapbio.org | @asapbio_).
60 episodes
Share
